{"title":"肝癌局部消融治疗的研究进展。","authors":"Ying-Bin Zheng, Yun Zheng","doi":"10.5732/cjc.009.10018","DOIUrl":null,"url":null,"abstract":"<p><p>After developing for more than 20 years, image-guided local ablation therapy has become one of the major treatments of hepatocellular carcinoma (HCC). In particular, percutaneous radio-frequency ablation has been widely accepted as the first-line treatment of early-stage HCC. A number of randomized controlled trials have shown some differences between these local ablation techniques. This article reviewed the development of local ablation therapy in the past few years.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 11","pages":"1219-24"},"PeriodicalIF":0.0000,"publicationDate":"2009-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research advancement in local ablation therapy for liver cancer.\",\"authors\":\"Ying-Bin Zheng, Yun Zheng\",\"doi\":\"10.5732/cjc.009.10018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>After developing for more than 20 years, image-guided local ablation therapy has become one of the major treatments of hepatocellular carcinoma (HCC). In particular, percutaneous radio-frequency ablation has been widely accepted as the first-line treatment of early-stage HCC. A number of randomized controlled trials have shown some differences between these local ablation techniques. This article reviewed the development of local ablation therapy in the past few years.</p>\",\"PeriodicalId\":7559,\"journal\":{\"name\":\"Ai zheng = Aizheng = Chinese journal of cancer\",\"volume\":\"28 11\",\"pages\":\"1219-24\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ai zheng = Aizheng = Chinese journal of cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5732/cjc.009.10018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ai zheng = Aizheng = Chinese journal of cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5732/cjc.009.10018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Research advancement in local ablation therapy for liver cancer.
After developing for more than 20 years, image-guided local ablation therapy has become one of the major treatments of hepatocellular carcinoma (HCC). In particular, percutaneous radio-frequency ablation has been widely accepted as the first-line treatment of early-stage HCC. A number of randomized controlled trials have shown some differences between these local ablation techniques. This article reviewed the development of local ablation therapy in the past few years.